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Identification of a Signaling Pathway
Involved in Calcium Regulation
of BDNF Expression
The importance of neuronal activity and synaptic stimu-
lation in thalamocortical development has been subse-
quently confirmed in several major studies (reviewed
by Shatz, 1990). For example, it has been shown that
pharmacological blockade of afferent input to cortical
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neurons by intra-ocular injections of tetrodotoxin (TTX,*Department of Developmental Neuroscience
a drug that blocks action potentials by blocking Na1Uppsala University
channels) in vivo prevents the segregation of LGN axonsS-751 23 Uppsala
into ocular dominance columns (Stryker and Harris,Sweden
1986), and synaptic transmission via one of the gluta-
mate receptors (the NMDA receptor) has been shown
to be necessary for the shift in ocular dominance caused
Summary by monocular deprivation (Kleinschmidt et al., 1987).
While it is now generally recognized that synaptic activ-
A signaling pathway by which calcium influx regulates ity can have a profound effect on thalamocortical con-
the expression of the major activity-dependent tran- nectivity, the molecular mechanisms that underlie activ-
script of BDNF in cortical neurons has been eluci- ity-dependent cortical development have not yet been
dated. Deletion and mutational analysis of the pro- identified.
moter upstream of exon III reveals that transactivation Many of the investigations on mechanisms of thala-
of the BDNF gene involves two elements 59 to the mocortical development have been driven by the hy-
mRNA start site. The first element, located between pothesis that thalamic axons compete for growth-pro-
72 and 47 bp upstream of the mRNA start site, is a moting factors produced by cortical neurons, and that
novel calcium response element and is required for this competition favors correlated activity between tha-
calcium-dependent BDNF expression in both embry- lamic neurons and their postsynaptic targets. One class
onic and postnatal cortical neurons. The second ele- of molecules that may serve as target-derived trophic
ment, located between 40 and 30 bp upstream of the factors are the neurotrophins.Neurotrophins are a family
mRNA start site, matches the consensus sequence of of small secreted proteins related to nerve growth factor
(NGF) (Levi-Montalcini, 1987; Crowley et al., 1994) anda cAMP response element (CRE) and is required for
include brain-derived neurotrophic factor (BDNF) (Bardetransactivation of the promoter in postnatal but not
et al., 1982; Leibrock et al., 1989; Ernfors et al., 1994b;embryonic neurons. The CRE-dependent component
Jones et al., 1994), neurotrophin-3 (NT-3) (Hohn et al.,of the responseappears to be mediated by CREB since
1990; Ernfors et al., 1994a), and neurotrophin 4/5 (NT-it is part of the complex that binds to this CRE, and
4/5) (Berkemeier et al., 1991; Hallbook et al., 1991; Con-since dominant negative mutants of CREB attenuate
over et al., 1995; Liu et al., 1995). The developmentaltransactivation of the promoter. A constitutively active
and spatial pattern of expression of the neurotrophinsmutant of CaM kinase IV, but not of CaM kinase II,
and their receptors (reviewed by Chao, 1992; Barbacid,leads to activation of the promoter in the absence of
1995), along with emerging experimental evidence, sug-extracellular stimuli, and partially occludes calcium-
gests that specific neurotrophins are involved in regulat-dependent transactivation. The effects of CaM kinase
ing particular aspects of cortical development (BozziIV on the promoter require an intact CRE. These mech-
et al., 1995; McAllister et al., 1995, 1997; reviewed byanisms, which implicate CaM kinase IV and CREB in
Bonhoeffer, 1996; Ghosh, 1996; Shieh and Ghosh, 1997).the control of BDNF expression, are likely to be cen-
Of particular relevance to the problem of activity-depen-trally involved in activity-dependent plasticity during
dent development are recent observations that suggestdevelopment.
that BDNF may play an important role in regulating thala-
mocortical development. Cabelli et al. (1995) have re-
Introduction ported that infusion of BDNF or NT-4/5 during the critical
period prevents the formation of ocular dominance col-
Sensory stimulation can have profound effects on the umns, consistent with the possibility that thalamic axons
development of the nervous system. Our understanding normally compete for limiting amounts of BDNF or NT-
of activity-dependent development is largely derived 4/5. In addition, Galuske et al. (1996) have shown that
from the pioneering studies of Hubel and Wiesel on the intracortical administration of BDNF reverses the activ-
development of ocular dominance columns in the visual ity-dependent shift of ocular dominance columns. More
cortex (Hubel and Wiesel, 1970). Monocular deprivation recently, Cabelli et al. (1997) have shown that infusion
during the critical period leads to a permanent shift in of TrkB receptor bodies also prevents ocular dominance
ocular dominance in favor of the nondeprived eye. The column formation, and in related experiments we have
found that intracortical injections of anti-BDNF or TrkB±anatomical basis of this shift is an expansion of lateral
IgG inhibits the growth of thalamic axon terminals ingeniculate nucleus (LGN) axon terminals receiving input
the rat barrel cortex (J. S. Roberts, D. Kim, and A. G.,from the nondeprived eye within layer 4 of visual cortex.
unpublished data). These observations suggest that en-
dogenous levels of BDNF play an important role in regu-
lating thalamic innervation of the cortex.²To whom correspondence should be addressed.
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Electrophysiological studies have provided additional on our findings on the mechanisms by which VSCC
activation leads to transactivation of the exon III pro-evidence in support of a role for BDNF in synaptic plas-
ticity. It has been reported that BDNF can enhance the moter in cortical neurons.
efficacy of synaptic transmission in hippocampal and
cortical slices (Kang and Schuman, 1995; Figurov et
Resultsal., 1996; Akaneya et al., 1997) and that treatment with
TrkB±IgG or the Trk receptor inhibitor, K252a, prevents
To begin to understand the mechanisms by which VSCCthe induction of long-term potentiation in both prepara-
activation regulates the expression of exon III±con-tions (Akaneya et al., 1997; Kang et al., 1997). Moreover,
taining transcripts, our first goal was to identify regionshippocampal slices from mice with a targeted disruption
of the gene that confer calcium responsiveness uponof BDNF show a defect in synaptic plasticity (Korte et
the promoter. Based on the genomic structure of mostal., 1995; Patterson et al., 1996). This defect can be
transcriptionally regulated genes, we suspected that se-rescued by viral expression of BDNF in slices (Korte et
quences 59 to the exon III mRNA start site should containal., 1996) or by bath application of BDNF (Patterson et
such calcium response elements, and we created a con-al., 1996), suggesting an acute requirement for BDNF in
struct in which putative exon III promoter and transcriptthis process. Interestingly, the defect is seen in both
sequences were placed 59 to a chloramphenicol acetylhomozygous null and heterozygous animals, indicating
transferase (CAT) coding sequence. This construct, de-that a critical level of BDNF may be required for activity-
noted -4100BIII-CAT, begins 4100 bp upstream of thedependent synaptic modifications. Although the precise
mRNA start site and contains 285 bp of exon III se-role of BDNF in synaptic physiology is not yet fullyunder-
quence. To determine whether the DNA sequencesstood, these studies suggest that BDNF is likely to play
present in this construct were sufficient to mediate aan important role in modulating synaptic function.
calcium response, the construct was transfected intoTo explore the possibility that BDNF may be involved
embryonic day 18 (E18) cortical cultures at three daysin activity-dependent cortical development, we initially
in vitro (E18 1 3DIV) using a modified calcium phosphateexamined the role of BDNF in the activity-dependent
transfection procedure (Threadgill et al., 1997). Twosurvival of cortical neurons (Ghosh et al., 1994). We
days later, the cultures were depolarized with 50 mMfound that the survival of cortical neurons in culture
KCl to activate VSCCs, and the cells were harvested atis enhanced by membrane depolarization and requires
various times after stimulation to assess reporter activ-calcium influx via voltage sensitive calcium channels
ity. (In this and all subsequent experiments, the cells(VSCCs). We then considered the possibility that cal-
were stimulated in the presence of 100 mM APV to pre-cium influx may lead to increased survival by modulating
vent activation of the NMDA receptors.) As shown inBDNF levels and found that VSCC activation indeed
Figure 1A, CAT assays revealed that this reporter wasleads to a robust increase in BDNF expression, that BDNF
robustly stimulated by VSCC activation. Elevations inis a trophic factor for cortical neurons, and that neutraliz-
CAT activity were first detectable at 4 hr and continueding antibodies to BDNF block the activity-dependent
to increase until about 10 hr of stimulation. This kineticssurvival of these cells (Ghosh et al., 1994). Consistent
of activation is consistent with our previous studies,with this observation, several other groups have also
which had shown that BDNF mRNA peaked between 4reported regulation of BDNF in vivo and in vitro by neu-
and 6 hr following VSCC activation (Ghosh et al., 1994),ronal activity (Isackson et al., 1991; Castren et al., 1992;
and suggested the presence of a calcium response ele-Lauterborn et al., 1996; see also Meyer-Franke et al.,
ment within the 4100 bp fragment. Transactivation of1995), suggesting that activity-dependent regulation of
-4100BIII-CAT was attenuated by EGTA and nifedipineBDNF may be broadly involved in mediating adaptive
(Figure 1B), indicating that transcriptionof the transgenechanges in the nervous system. It is therefore of interest
was regulated by calcium influx via VSCCs, as had pre-to understand the molecular mechanisms by which neu-
viously been described for the endogenous gene.ronal activity leads to transcription of the BDNF gene.
To further define the DNA sequences in the BDNFThe BDNF gene consists of five exons, with thecoding
promoter required for calcium-dependent transcription,region included entirely within exon V. Each of the first
a series of deletion constructs were created that pro-four exons has a putative promoter on its 59 flanking
gressively removed 59 sequences from the -4100BIII-region and a splice donor site on its 39 end. Exon V
CAT reporter (Figure 2A). These constructs were trans-contains the only splice acceptor site on its 59 end and
fected into E18 cortical cultures at 3DIV, and at 5DIVtwo alternative polyadenylation sites on its 39 end. Each
the cells were stimulated and harvested for CAT assays.of the four 59 exons can therefore bealternatively spliced
The distal deletionconstructs, which included 1500, 634,with exon V,and theuse of two alternate polyadenylation
and 108 bp of 59 sequence, were all capable of mediatingsites can give rise to eight different BDNF transcripts
a robust calcium response comparable to that seen(Timmusk et al., 1993). Experiments using exon-specific
with -4100BIII-CAT (data not shown), suggesting theprobes have indicated that the four 59 exons are differen-
presence of a major calcium response element withintially responsive to neuronal activity, and that exon III±
the 108 bp promoter fragment. Further analysis of dele-containing transcripts are most robustly regulated by
tion constructs in E18 cultures indicated that whereasactivity in the hippocampus and cortex (Metsis et al.,
constructs that included 108 or 72 bp of upstream se-1993; Timmusk et al., 1995; Lauterborn et al., 1996). We
quence could mediate a robust calcium response, con-and others have previously shown that activity-depen-
structs that included 47 or 30 bp of upstream sequencedent BDNF expression is mediated largely by calcium
influx via VSCCs (Ghosh et al., 1994). Here, we report were only weakly responsive or nonresponsive to VSCC
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this region as calcium-responsive sequence I (CRS-I) to
distinguish it fromthe previously described calcium/cAMP
response element (CaRE/CRE; Sheng et al., 1990).
We were also interested in determining whether the
CRS-I was involved in regulating BDNF expression in
postnatal neurons, since distinct roles of BDNF during
embryonic and postnatal development may require dif-
ferent formsof regulatory control. For example, the regu-
latory mechanisms important in the embryonic cortex
where BDNF may function as a trophic factor (Ghosh et
al., 1994) may be distinct from those that are important
in postnatal neurons where BDNF may mediate aspects
of cortical plasticity (Cabelli et al., 1995, 1997; Akaneya
et al., 1997). To identify regions of the gene that are
involved in calcium-dependent expression in postnatal
neurons, P1 cortical cultures were transfected with the
reporter constructs described above, and once again
an element between -72 and -47 was found to be re-
quired for transactivation (Figure 2C). These experi-
ments indicate that the CRS-I functions as a calcium
response element in both embryonic and postnatal cor-
tical neurons.
To further characterize the sequences between -47
and -72 that were involved in mediating a calcium re-
sponse, we generated reporter constructs that had mu-
tations within this region. As shown in Figure 3A, in E18
cortical cultures mutations between -57 and -64 as well
as mutations between -65 and -72 attenuated calcium-
dependent transactivation. These results indicate that
sequences between -57 and -72 are important for the
calcium responsiveness of CRS-I.
Previous studies of calcium signaling pathways have
indicated that DNA sequences upstream of the mRNA
start site can have more than one calcium-responsive
element. For example, the c-fos promoter, which has
long served as a model for calcium-regulated transcrip-
tional activation, contains two calcium response ele-
mentsÐthe serum response element (SRE) at -300 and
the cAMP/calcium response element (CRE) at -60 (Sheng
et al., 1988; Misra et al., 1994). To determine if the BDNF
promoter might similarly contain calcium response ele-
ments in addition to CRS-I, we carried out a sequence
analysis of the promoter and found the sequence TCACFigure 1. A Reporter Construct that Includes 4100 bp of Sequence
Upstream of the Exon III mRNA Start Site Can Mediate Calcium- GTCA, located between -38 and -31, which closely
Dependent Transcription in Response to Depolarization of Cortical matches the consensus for a CRE (TGACGTCA) (Figure
Neurons 2D). Our deletion analysis suggested, however, that this
(A) CAT activity in E18 cortical neurons transfected with the reporter CRE, whichwe will refer toas BIII-CRE, was not sufficient
-4100BIII-CAT at 3DIV and stimulated for indicated times with 50 tomediate a calcium response since the construct -47BIII-
mM KCl (to activate VSCCs) at 5DIV.
CAT, which included the BIII-CRE sequence, was unable(B) CAT activity in E18 cortical cultures transfected with the reporter
to mediate calcium-dependent transactivation.-4100BIII-CAT at 3DIVand stimulated with 50 mM KCl in the absence
Although the deletionanalysis suggested that the BIII-or presence of EGTA (2 mM) or nifedipine (5 mM, 10 mM) for 10 hr
CRE was not sufficient to mediate a calcium response,at 5DIV. All KCl stimulations in this and other experiments shown
in this paper were performed in the presence of 100 mM APV to it did not rule out the possibility that this element might
inhibit activation of NMDA receptors. be required for calcium-dependent transactivation in the
context of the BDNF promoter. To examine this possibil-
activation (Figure 2B). These experiments indicate the ity, we created three constructs in which the BIII-CRE
presence of a calcium response element within the was mutated in context within the BDNF promoter. In
BDNF promoter located between 47 and 72 bp upstream one of the constructs, the BIII-CRE sequence was mu-
of the mRNA start site. Examination of the sequence tated (-108BIII-CAT(CRE-)) so that it no longer matched
in this region (Figure 2D) revealed no known calcium- the CRE consensus sequence necessary for binding
the transcription factor CREB (Montminy and Bilezikjian,responsive sequences, suggesting that this 25 bp DNA
sequence represents a novel calcium response element 1987; Sheng et al., 1990). In the second construct, se-
quences between -46 and -32 were deleted in a -108BIII-required for calcium regulation of BDNF exon III expres-
sion. We refer to the calcium-responsive element within CAT background (-108BIII-CAT[del 46±32]) to remove
Neuron
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Figure 2. A Calcium Response Element Located between72 and 47 bp Upstream of the Transcriptional Start Site Is Required for Transactivation
of the BDNF Promoter in Response to Depolarization
(A) Diagrammatic summary of promoter constructs used to identify the calcium-responsive region within the BDNF exon III promoter.
(B) Relative CAT activity in E18 cortical cultures transfected with indicated constructs at 3DIV, left unstimulated (-) or stimulated with 50 mM
KCl (1) at 5DIV.
(C) Relative CAT activity in P1 cortical cultures transfected with indicated constructs at 3DIV, left unstimulated (-) or stimulated with 50 mM
KCl (1) at 5DIV.
(D) Sequence of the region of the BDNF exon III promoter that mediates a calcium response. The region between -72 and -47 does not include
any known calcium response element. The region between -47 and -30 includes a CRE-like element (BIII-CRE) located between -38 and -31
(TCACGTCA).
the CRE sequences, and in the third construct the BIII- response. This construct was also calcium responsive
(comparable to -108BIII-CAT(CRE-)), indicating that se-CRE was mutated in context in a -72BIII-CAT back-
ground (-72BIII-CAT(CRE-)). To evaluate the role of BIII- quences between -72 and the BIII-CRE can mediate
calcium-dependent transactivation (data not shown).CRE sequences in calcium-dependent transactivation
of BDNF, these constructs were transfected into E18 Therefore, in E18 cultures the BIII-CRE contributes to
but is not absolutely necessary for a calcium response.and P1 cortical cultures at 3DIV, and the cells were
stimulated and harvested at 5DIV. As shown in Figure To determine if BIII-CRE functions in a similar way
in neonatal neurons, we transfected the various CRE3B, in E18 cortical cultures the deletion or the mutation
of the CRE site attenuated but did not abolish the cal- mutant reporters into P1 cortical cultures. The effects of
BIII-CRE mutations in P1 cultures were notably differentcium response, suggesting that in these cells the BIII-
CRE contributed to the calcium response but was not from what we had seen in E18 cultures. In these cultures,
as shown in Figure 3C, mutations of the BIII-CRE com-required for calcium-dependent transactivation of the
promoter. To determine whether this CRE-independent pletely prevented calcium-dependent transactivation of
the reporter, indicating that BIII-CRE sequences werecomponent of the calcium response was mediated by
sequences downstream of -72, we examined the ability absolutely necessary for a calcium response in this age.
These experiments strongly suggest that the BIII-CREof the construct -72BIII-CAT(CRE-) to mediate a calcium
Calcium Regulation of BDNF Expression
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Figure 3. Mutational Analysis of the BDNF Promoter
E18 and P1 cortical cultures were transfected with constructs indi-
cated at 3DIV and stimulated with 50 mM KCl at 5DIV.
(A) Relative CAT activity in E18 cortical cultures transfected with
-72BIII-CAT or with constructs that have in-context mutations be-
tween -57 and -72, as indicated.
(B) Relative CAT activity in E18 cultures transfected with -108BIII-
CAT or with constructs that have mutations that disrupt BIII-CRE.
(C) Relative CAT activity in P1 cortical cultures transfected with
-108BIII-CAT or with constructs that have mutations that disrupt
BIII-CRE.
functions as a developmental stage-specific calcium re- seen in 72±47 shifts with E18 extracts (indicated with
an arrow) is barely apparent in shifts with P1 extractssponse element within the BDNF promoter, and that it
is a critical mediator of calcium responses in postnatal (Figure 4A). A failure of this complex to effectively form
in P1 cells may account for the absence of a BIII-CRE±neurons.
The promoter analysis experiments described above independent pathway for transactivation in P1 cultures.
The results of these gel shift experiments are consistentsuggested the involvement of two elements in calcium
regulation of BDNF expression. We were therefore inter- with the promoter analysis experiments described ear-
lier and suggest that the complex we see shifted withested in characterizing the proteins that bind to the BDNF
promoter to see if we could find evidence for the forma- 72±47 binds to CRS-I. The oligonucleotides 47±20 as
well as 56±30 shift a complex not present in shifts withtion of two separate protein complexes in the proximal
region of the BDNF promoter. For these experiments, 72±47, and we infer that this complex should include
protein(s) that bind to BIII-CRE.we made nuclear protein extracts from E18 and P1 cells
in culture, and used the extracts in gel mobility shift To determine whether the BIII-CRE sequence could
in fact bind to CREB, we carried out a series of gel shiftexperiments with three oligonucleotides that spanned the
sequence between -72 and -20. As shown in Figure 4A, experiments with a recombinant CREB peptide (which
includes the DNA-binding domain [CREB1 bZIP; Santashifts with E18 extracts clearly indicated the existence
of two protein complexes at the promoter. Importantly, Cruz]). As shown in Figure 4B, the recombinant CREB
peptide could shift oligonucleotides containing a con-the 72±47 oligonucleotide and the47±20 oligonucleotide
shifted distinct complexes, indicating that one complex sensus CRE, 56±30, and 47±20; the peptide, however,
failed to shift oligonucleotides containing 72±47 and 72±forms between -72 and -47 and a second complex forms
between -47 and -20. Gel shifts with P1 extracts were 40, indicating that CREB can bind to a sequence be-
tween -40 and -30. Moreover, an oligonucleotide thatqualitatively similar to those with E18 extracts with one
noteworthy difference. The complex that can clearly be contain a mutated CRE, 47±20 (CRE-), could not be
Neuron
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Figure 4. Analysis of Protein Complexes at the BDNF Promoter
(A) At least two different protein complexes bind to the BDNF promoter bewteen 72 and 30 bp upstream of the mRNA start site. Nuclear
protein extracts from E18 and P1 cultures were used to shift indicated 32P-labeled double-stranded oligonucleotides in the absence (-) or
presence (1) of 100-fold excess unlabeled (cold) competitor as described in the Experimental Procedures. Note that the complex in the 72±47
lane (indicated by an arrow) moves at a different mobility than the major complex in the 56±30 and 47±20 lanes. Note also that the complex
at 72±47 is more abundant in E18 extracts compared to P1 extracts. The lower shifted band represents a nonspecific DNA±protein interaction
since it is present in all lanes and is competed by DNA sequences unrelated to the BDNF promoter (data not shown).
(B) A recombinant CREB peptide can bind to the BDNF promoter in a CRE-dependent manner. A recombinant peptide containing the DNA-
binding domain of CREB (see Experimental Procedures) was used in gel shift experiments with indicated oligonucleotides. CRE: consensus
CRE from the c-jun promoter; 72±47, 72±40, 56±30, 47±20: fragments of the BDNF promoter; 47±20(CRE-): 47±20 oligonucleotide with a
mutation in BIII-CRE to alter it from consensus CREB-binding sequence; and 47±20(CRE1): 47±20 oligonucleotide with a base substitution
so that the BIII-CRE (TCACGTCA) is changed to a perfect CRE (TGACGTCA). The arrow indicates the location of the shifted complex.
(C) CREB is part of the complex that binds to BIII-CRE. Antibodies to CREB, but not to ATF-1 or ATF-2, can supershift the protein complex
from P1 cultures, which binds to the 56±30 oligonucleotide. Similar results were obtained with extracts from E18 cultures (data not shown).
Anti-CREB(p): polyclonal antibody to CREB; anti-PCREB: polyclonal antibody to phosphorylated CREB (serine 133); anti-CREB(m): monoclonal
antibody to CREB; and anti-ATF-1, anti-ATF-2: monoclonal antibodies to ATF-1 and ATF-2.
(D) A protein complex that binds to the 72±30 fragment of the BDNF promoter independent of the BIII-CRE is regulated by stimulation
(depolarization). Nuclear proteins from unstimulated E18 cultures (-) or cultures stimulated with 50 mM KCl for 4 hr (1) were used to shift 32P-
labeled oligonucleotides in the absence (comp. 2) or presence (comp. 1) of 100-fold excess cold competitor. Note that the shifted complex
is present only in stimulated cultures.
shifted by the recombinant CREB, indicating that CREB members ATF-1 and ATF-2. As shown in Figure 4C,
addition of two different CREB antibodies led to super-binds to the BIII-CRE sequence within the BDNF pro-
moter (Figure 4B). shifted complexes (top two arrows), indicating that the
complex contains CREB. The shifted complexes did notTo examine more directly whether the BDNF pro-
moter±binding activity in nuclear extracts contains CREB show a supershift with antibodies to ATF-1 and ATF-2,
arguing in favor of thepresence of CREBand not anotheror a CREB family protein, we carried out a series of gel
shift experiments with the 56±30 oligonucleotide in the CREB family member in the complex. This conclusion
is further reinforced by the fact that the pattern of shiftspresence of antibodies to CREB and to CREB family
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and supershifts seen with the 56±30 oligonucleotide was
virtually identical to the pattern of shifts seen with a
consensus CRE oligonucleotide (derived from the c-jun
promoter), and that excess of this cold consensus CRE
could compete the complex that shifts 56±30 (Figure
4C). Similar results were obtained with nuclear extracts
from bothE18 and P1 cultures. (An antibody tophospho-
CREB was unable to supershift either the 56±30 oligonu-
cleotide or a consensus CRE; this failure was most likely
due to dephosphorylation of CREB during the nuclear
protein isolationprocedure, since in the absence of stim-
ulus CREB gets dephosphorylated quite rapidly [S.-C. H.
and A. G., unpublished data]).
It is known that CREB can bind to the CRE in the
absence of stimulus. To determine whether the binding
of other cellular proteins to the BDNF promoter was also
stimulus independent, we carried out shifts with the
fragment 72±30 with extracts from stimulated and un-
stimulated E18 cortical neurons. As shown in Figure 4D,
extracts from stimulated but not unstimulated neurons
caused a strong shift of this DNA fragment. Moreover,
the formation of this complex did not require an intact
CRE, since mutations within BIII-CRE did not affect for-
mation of this complex. These experiments indicate that
the formation of a major protein±DNA complex at the
BDNF promoter is calcium dependent, and it is reason-
able to speculate that the calcium-dependent formation
of this complex might play an important role in calcium-
dependent transactivation of the reporter.
Although the gel shift experiments suggest that CREB
is part of a complex that forms at the BDNF promoter,
they do not indicate whether CREB is functionally re-
quired for transactivation of the promoter. In the next
series of experiments, we thereforeexamined the effects
of expressing a dominant negative mutant of CREB
(KCREB; Walton et al., 1992) on transactivation of the
-108BIII-CAT reporter. Strikingly, the results of this ex-
periment were very similar to the effects of BIII-CRE
mutations. Whereas KCREB completely abolished cal-
cium-dependent transactivation in P1 cultures, it attenu-
ated but did not abolish transactivation in E18 cultures
(Figure 5). These experiments indicate that CREB-depen-
dent transcription is important for transactivation of the
BDNF promoter in both E18 and P1 cultures, and they
also support the existence of a CREB-independent
transactivating mechanism that can function in E18 cul- Figure 5. Expression of a Dominant Negative CREB Attenuates
tures. Transactivation of the BDNF Promoter
In our final series of experiments, we investigated (A and B) Relative CAT activity in E18 (A) and P1 (B) cultures
transfected with -108BIII-CAT together with a control vector or dom-the mechanism by which the calcium signal might be
inant negative CREB (KCREB). Cells were transfected at 3DIV andpropagated to thenucleus to regulate BDNF expression.
stimulated with 50 mM KCl at 5DIV.The calcium/calmodulin-dependent protein kinases, CaM
kinase II and CaM kinase IV, have been shown to mediate
several calcium-dependent biochemical and physiologi-
IV are expressed in cortical cultures. Consistent withcal changes in neurons. Importantly, both CaM kinase
the distribution reported in hippocampal cultures (BitoII and CaM kinase IV can phosphorylate the transcription
et al., 1996), in cortical neurons CaM kinase II is presentfactor CREB and have been implicated in calcium regu-
predominantly in the cytoplasm, and CaM kinase IV islation of the c-fos gene (Sheng et al., 1991; Matthews
present primarily in the nucleus (Figure 6), suggestinget al., 1994; Sun et al., 1994). To determine whether CaM
that one or both of these kinases might be involved inkinase II or CaM kinase IV might be involved in calcium
propagating the calcium signal to the nucleus.regulation of BDNF expression, we first examined the
To evaluate more directly the role of CaM kinase indistribution of these two kinases in cortical cultures. As
BDNF expression, we next examined the effects ofshown in Figure 6, immunofluorescence using mono-
clonal antibodies indicated that both CaM kinase II and transfecting wild type and constitutively active mutants
Neuron
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Figure 6. Distribution of CaM Kinase II and CaM Kinase IV in E18 Cortical Neurons in Culture Revealed by Immunofluorescence Using
Monoclonal Antibodies to CaM Kinase II and CaM Kinase IV
Note that CaM kinase II, but not CaM kinase IV, is largely excluded from the nucleus.
of CaM kinase II and IV on BDNF transcription. The the promoter (compare 2 and 1 lanes in cells trans-
fected with CaM kinase IV ca), which is consistent withconstitutively active mutants used in this experiment
were deletion mutations in which the autoinhibitory do- CaM kinase IV being part of the normal signaling path-
way by which calcium influx leads to BDNF expression.main of the kinase had been removed (Sun et al., 1994).
In this series of experiments, wild type and constitutively Finally, to determine whether CaM kinase IV modulates
transactivation via CRS-I, BIII-CRE, or both, we exam-active mutants of CaM kinase II or IV were cotransfected
with -634BIII-CAT (data not shown) or -108BIII-CAT (Fig- ined the effects of expressing wild-type and constitu-
tively active CaM Kinase IV on transactivation via theure 7). As shown for E18 (Figure 7A) and P1 (Figure 7D)
cultures, calcium-dependent transactivation was pre- -108BIII-CAT(CRE-) reporter. As shown in Figure 7C,
constitutively active CaM kinase IV was not sufficientserved in cells expressing wild-type CaM kinase II, al-
though the level of transactivation was somewhat at- to activate transcript of this mutated reporter construct,
indicating that CaM kinase IV acts via the BIII-CRE totenuated in P1 cultures (cf. Figure 2). Expression of
constitutively active CaM kinase II, however, almost regulate transcription.
Finally, to determine whether CaM kinase IV activitycompletely inhibited transactivation of the promoter in
both E18 and P1 cultures (Figures 7A and 7D). These was necessary for calcium-dependent transactivation
of BDNF, we examined the effects of inhibiting CaMexperiments suggest that activation of CaM kinase II is
unlikely to be directly involved in transactivation of the kinase IV using an inacative CaM kinase IV construct
(DCaM kinase IV/Gr(i); Ho et al., 1996). OverexpressionBDNF promoter (see Discussion).
The effects of expressing CaM kinase IV constructs of this construct has been shown to exhibit a dominant
negative effect on endogenous CaM kinase IV (Fink-were quite different from those of expressing CaM Ki-
nase II.Although theexpression of wild-type CaM kinase beiner et al., 1997). As shown in Figure 7F, expression of
dominant negative CaM kinase IV markedly attenuatedIV did not have a marked effect on the induction of
the reporter constructs, in both E18 and P1 cultures calcium-dependent transactivation of the reporter -72BIII-
CAT. This observation, taken togetherwith theocclusionexpression of constitutively active CaM kinase IV was
sufficient for transactivation of the BDNF promoter even effect of constitutively active CaM kinase IV described
above, strongly suggests that calcium-dependent acti-in the absence of stimulus (Figures 7B and 7E). In addi-
tion, expression of constitutively active CaM kinase IV vation of the BDNF gene is mediated via activation of
CaM kinase IV.largely occluded calcium-dependent transactivation of
Figure 7. Effects of Perturbing CaM Kinase Activity on Transactivation of the BDNF Promoter
(A±C) Relative CAT activity in E18 cultures transfected with indicated BDNF reporter constructs together with wild-type (wt) or constitutively
active (ca) CaM kinase II or CaM kinase IV at 3DIV and stimulated with 50 mM KCl at 5DIV.
(D and E) Relative CAT activity in P1 cultures transfected with indicated BDNF reporter constructs together with wild-type (wt) or constitutively
active (ca) CaM kinase II or CaM kinase IV at 3DIV and stimulated with 50 mM KCl at 5DIV. Note that the effect of CaM kinase IV on
transactivation (B) is abolished when the CRE is mutated in the reporter (C), indicating that CaM kinase IV acts via the CRE to mediate
transactivation.
(F) Relative CAT activity in P1 cultures transfected with -72BIII-CAT together with a control vector or dominant negative mutant of CaM kinase
IV at 3DIV and stimulated with 50 mM KCl at 5DIV.
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Figure 8. Diagrammatic Representation of the
Proposed Mechanism by which Calcium In-
flux Regulates BDNF Expression
Transactivation of the BDNF promoter is me-
diated by two elements, CRS-I and BIII-CRE.
The BIII-CRE±dependent component of trans-
activation is mediated by CREB and can be
regulated by CaM kinase IV.
Discussion embryonic neurons, suggesting that CRS-I is both nec-
essary and sufficient for calcium-dependent transacti-
vation. Gel mobility shift experiments indicate sequencesIn this study, we have examined the mechanism by
between -47 and -72 bind to a complex that is morewhich calcium influx via voltage-sensitive calcium chan-
abundant in nuclear extracts of E18 cultures than innels regulates the expression of BDNF in cortical neu-
extracts of P1 cultures. Importantly, we find that therons. We have focused on analysis of the promoter of
CRE-independent complex that forms at the BDNF pro-exon III, which is the major activity-regulated exon of
moter is regulated by activity. It will be of interest tothe BDNF gene. Our deletionanalysis as well as pharma-
determine if this reflects activity-dependent DNA bind-cological and molecular perturbation experiments sug-
ing of an existing protein complex or the activity-depen-gest that calcium-dependent transcription of the BDNF
dent synthesis of proteins that are involved in regulatinggene is mediated by elements located within 72 bp up-
BDNF transcription. It is likely that this complex containsstream of the exon III mRNA start site. This segment of
the transcription factor that mediates transactivation viathe promoter contains two elements that contribute to
CRS-I. The signaling mechanisms involved in mediatingthe calcium response. The first element, denoted CRS-I,
transactivation via CRS-I have not yet been identified.is located between -72 and -47 and is required for induc-
Our experiments, however, indicate that unlike trans-tion of exon III in both embryonic and postnatal cortical
activation via the BIII-CRE, CaM kinase IV is neithercultures. The second element is located between -40
sufficient nor necessary for transactivation via CRS-I.and -30 bp upstream of the mRNA start site, contains
Our experiments indicate that together with CRS-I, thea CRE-like sequence (TCACGTCA), and is required for
BIII-CRE contributes significantly to calcium-dependentcalcium-dependent transactivation of BDNF inpostnatal
transactivation. In embryonic cultures, in-context mu-but not embryonic cultures. Based on this analysis, we
tations of the BIII-CRE attenuate calcium-dependentconclude that calcium-dependent BDNF gene expres-
transactivation, and in postnatal cultures the same mu-sion is mediated by distinct mechanisms in embryonic
tations completely abolish the calcium response. There-and postnatal cortical cultures. In embryonic cultures,
fore, the BIII-CRE contributes to calcium-dependentCRS-I can function in a BIII-CRE±independent manner
transactivation at all ages and is absolutely required in
to mediate calcium-dependent transactivation. In post-
postnatal cultures. Several lines of evidence suggest
natal cultures, two elements, CRS-I and BIII-CRE, coop-
that the BIII-CRE component of the calcium-dependent
erate to mediate a calcium response. transactivation is mediated by CREB. First, the BIII-CRE
One of the major findings of this study is the identifica- (TCACGTCA) closely resembles a perfect CRE (TGACG-
tion of a novel calciumresponse sequence,CRS-I, which TCA), suggesting that the BIII-CRE might function as a
is involved in calcium-dependent expression of BDNF. binding site for CREB. Second, recombinant CREB
Based on deletion analysis, this element is located be- binds to oligonucleotides derived from the BDNF pro-
tween -72 and -47 and is required for calcium-depen- moter in a BIII-CRE±dependent manner. Third, gel mo-
dent transactivation in both embryonic and postnatal bility shifts with a BDNF promoter fragment (56±30) are
neurons. Initial mutational analysis of the region between competed with cold consensus CRE oligonucleotides,
-72 and -47 indicates that sequences between -57 and indicating that the complex at the BDNF promoter con-
-72 contribute substantially to the responsiveness of the tains a CRE-binding protein. Fourth, two different anti-
CRS-I element. Although we do not know much about bodies to CREB (a polyclonal and a monoclonal), but
the transcription complex that forms at CRS-I, we can not antibodies to ATF-1 or ATF-2, supershift a complex
infer certain properties of this element based on muta- formed at the BDNF promoter, indicating that CREB is
tional analysis of the promoter and various gel shift part of the complex. Fifth, expression of K-CREB, a
assays. Importantly, this element can function in a CRE- dominant negative mutant of CREB, markedly attenu-
ates calcium-dependent transactivation of the promoter.independent manner to mediate a calcium response in
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These pieces of evidence taken together strongly sug- correlated with synaptic strengthening in cellular mod-
els of plasticity (Malinow et al., 1989; Silva et al., 1992).gest that the BIII-CRE contributes to calcium regulation
of BDNF and that this component of the calcium re- It should be noted, however, that the ability of activated
CaM kinase II to inhibit transactivation is similar to itssponse is mediated by CREB.
An interesting aspect of the way the BDNF promoter reported inhibition of CREB-dependent transcription in
PC12 cells (Sun et al., 1994). That study indicated thatseems to be regulated is the functional interaction be-
tween the CRS-I and BIII-CRE elements. Whereas CRS-I constitutively active mutants of CaM kinase II led to
phosphorylation of CREB at serine 142 in addition tocan function independently of BIII-CRE in embryonic
cultures, it requires the presence of BIII-CRE in the pro- serine 133, and this second phosphorylation appeared
to inhibit the CREB-mediated transcription. Unlike wild-moter to mediate a calcium response in postnatal cul-
tures. This cooperation between the CRS-I and BIII-CRE type CaM kinase II, the constitutively active mutants of
CaM kinase II can translocate to the nucleus and there-is reminiscent of growth factor regulation of the c-fos
promoter. In that case, the c-fos CRE by itself cannot fore can directly phosphorylate CREB at an inhibitory
site. The effect of constitutively active CaM kinase II onmediate a growth factor response, much as the BIII-
CREby itself cannotmediate calcium-dependent activa- transactivation may therefore be related to its ability to
translocate to the nucleus. In coexpression experiments,tion of the BDNF promoter. In the context of the full
promoter, however, the c-fos CRE cooperates with the we have found that constitutively active CaM kinase
II inhibits constitutively active CaM kinase IV±inducedserum response element (SRE) to mediate transactiva-
tion (Ginty et al., 1994; Bonni et al., 1995). In an analo- transactivation of the BDNF promoter, suggesting that
the effects of CaM kinase II in this context may be medi-gous manner, we propose that BIII-CRE cooperates with
CRS-I to mediate calcium-dependent transactivation of ated by a similar phosphorylation event.
Our observations are most consistent with the inter-the BDNF promoter in postnatal neurons.
One of the most striking observations of this study is pretation that CaM kinase IV mediates calcium activa-
tion of the BDNF promoter, since we find that expressionthe developmental stage-specific use of the BIII-CRE
sequences. Whereas mutations of this site do not pre- of a constitutively active mutant of CaM kinase IV is
sufficient for transactivation of the promoter in the ab-vent calcium-dependent transactivation of the promoter
in E18 cultures, the same mutations completely block sence of extracellular stimulation, since expression of
a constitutively active mutant of CaM kinase IV largelycalcium-dependent transcription in postnatal cultures.
This is a noteworthy finding, since it suggests that the occludes calcium-dependent transactivation of the BDNF
promoter, and since inactive, dominant negative mu-BIII-CRE can act as a gate that can regulate calcium-
dependent transcription at particular developmental tants of CaM kinase IV largely inhibit calcium-dependent
transactivation. The effect of CaM kinase IV on the pro-stages. The fact that a stringent dependence on the BIII-
CRE should emerge in postnatal cultures is particularly moter requires the presence of BIII-CRE, suggesting
that the CaM kinase IV effect is mediated by CREB.interesting, since the cortex begins to receive environ-
mental stimuli during postnatal development and under- Such an interpretation would be consistent with previ-
ous reports (Sun et al., 1994), which indicate that CREBgoes a period of activity-dependent plasticity. Based on
recent evidence that BDNF may be involved inmediating is directly phosphorylated by CaM kinase IV at serine
133. We therefore propose that the BIII-CRE componentaspects of activity-dependent plasticity (reviewed by
Bonhoeffer, 1996; Shieh and Ghosh, 1997), we would of transactivation is mediated by CaM kinase IV, which
acts by phosphorylating CREB at serine 133. We shouldsuggest that transcriptional gating in postnatal cultures
via the BIII-CRE provides a mechanism for the produc- also note that since CRE mutations abolish CaM ki-
nase IV effects on the promoter, but do not abolishtion of BDNF only in response to stimuli that can lead
to long-term adaptive changes. For example, only those calcium-dependent transactivation of the promoter in
embryonic cultures, the BIII-CRE±independent compo-presynaptic stimuli that lead to firing of the postsynaptic
neurons may be effective in activating the signaling path- nent of transactivation (via CRS-I) is likely to involve
another pathway.way that controls BIII-CRE±dependent transcription.
Analysis of the signaling pathways involved in regula- Given the evidence that BDNF may be involved in
synaptic strengthening, theobservation that CaM kinasetion of BDNF expression fits well with this model. It has
been previously reported that CREB can be phosphory- IV may regulate transactivation of the BDNF gene is
interesting, since it suggests a mechanism that may belated by CaM kinases at serine 133 (Gonzalez and Mont-
miny, 1989; Sheng et al., 1991; Matthews et al., 1994; involved in activity-dependent plasticity in postnatal
neurons. Hebbian models of plasticity require correlatedSun et al., 1994), a site critical for CREB-dependent
transcription. Immunofluorescence experiments indicate activity of the pre- and postsynaptic neurons for strength-
ening of connections. If a synaptic input is weak andthat both CaMkinase II and CaMkinase IV areexpressed
in the cortical neurons in culture. We find that constitu- does not lead to a firing of the postsynaptic neuron, it
may not lead to the activation of VSCC at the somatively active mutants of CaM kinase IV can drive trans-
activation of the promoter in the absence of extracellular and the consequent activation of CaM kinase IV in the
nucleus. Such a stimulation would therefore not lead tostimuli, but that constitutively active mutants of CaM ki-
nase II have an opposite effect and inhibit calcium-depen- BDNF expression, and the synapse would not undergo
long-term strengthening or stabilization. In contrast,dent transactivation. The observation that expression
of a constitutively active mutant CaM kinase II inhibits strong stimuli that cause the postsynaptic cell to fire
action potentials would lead to the activation of CaMthe calcium-dependent expression of BDNF was sur-
prising, since activation of CaM kinase II is positively kinase IV and phosphorylation of CREB, which in turn
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DNA, 2 mg of DNA coding a candidate interacting protein (e.g., CaMwould lead to transactivation of the BDNF gene. BDNF
Kinase), and carrier DNA. Following a 20±30 min transfection duringthus produced could contribute to long-term synaptic
which a fine sandy precipitate covered the cells, the cultures werestrengthening and perhaps to the growth of pre- or post-
washed in DMEM and returned to the original culture media. The
synaptic processes. According to this model, the CaM efficiency was typically between 1% and 5%, and there was no
kinase IV±BDNF pathway could turn out to be a central apparent toxicity to the cells. In all cases, the DNA was purified by
two rounds of CsCl banding.component of activity-dependent plasticity in the devel-
oping cortex, a prediction that is testable at various
CAT Assayslevels.
Cells were harvested immediately after stimulation in isotonic TNE
(10 mM Tris [pH 7.8], 150 mM NaCl, 1 mM EDTA). Cells were spun
Experimental Procedures down gently and subjected to three cycles of freeze-thaw lysis.
Lysis supernatant was incubated with 0.5 mCi 14C-labeled chloram-
Primary Cell Cultures phenicol (Amersham) and 0.8 mmol acetyl CoA (Boehringer Mann-
Cortical neurons from E18 Long-Evans rat embryos or P1 Long- heim) at pH 7.8 and 378C for 1 hr. Reaction mixtures were extracted
Evans rat pups were cultured as previously described (Ghosh and with ethyl acetate, speedvacuumed, resuspended in chloroform,
Greenberg, 1995) with the following minor modifications. The cortex spotted on thin-layer chromatography (TLC) plates (J. T. Baker), and
was dissected in ice-cold HBSS (6.5 g/L glucose), digested in 10 separated by ascending chromatography for 2 hr (95% chloroform,
U/ml Papain in dissociation media (2 3 20 mins), and dissociated 5% methanol). Data from any single histogram are quantified from
in culture media. The dissociated neurons were plated on 60 mm experiments performed on cells that were simultaneously cultured,
plates precoated with poly-d-lysine and laminin at a density of 3 3 transfected, and assayed to minimize variability due to subtle differ-
106 cells per plate in either glutamine-free Basal Media Eagle (Sigma) ences in experimental procedure. Normalization was calculated rel-
supplemented with glutamine (to 1 mM), N2 (to 1%; GIBCO), and ative to an unstimulated control with the same reporter construct.
fetal bovine serum (5%) or in Neuralbasal Media (GIBCO) supple- Shown are representative examples of experiments that were per-
mented with glutamine (to 1 mM) and B27 (to 2%; GIBCO). formed two or more times. For measurements of relative CAT activ-
ity, levels of 14C emissions on TLC plates were quantified by phos-
phorimager scans.Plasmids
-4100BIII-CAT was construced by subcloning a 4.4 kbp HindIII/XbaI
Gel Mobility Shift Assaysfragment containing exon III into pBLCAT2 vector. -1500BIII-CAT,
Nuclear extracts were prepared using a rapid technique described-634BIII-CAT, and -108BIII-CAT were similarly construced from a
previously (Andrews and Faller, 1991) with the following modifica-1.8 kbp EcoRV/XbaI fragment, a 0.9 kbp HincII/XbaI fragment, and
tions. Cultured P1 and E18 cells were stimulated with 50 mM KCla EcoRI/XbaI fragment, respectively. -108BIII-CAT(CRE-) was con-
at 2DIV±5DIV as described earlier and scraped into 1.5 ml coldstructed by modified inverse PCR mutagenesis (Stratagene), using
phosphate-buffered saline (PBS). The cells were pelleted by centrif-the following two oligos: 59-CAGTCTAGAAGGAGGCAGCGTGGAGC
ugation for 2 min at 48C and then resuspended in 0.5 ml cold lysisCCTC-39 and 59-CAGTCTAGAGCTGTCATATGATACCTC-39, which
buffer (10 mM HEPES-KOH [pH 7.9], 1.5 mM MgCl2, 10 mM KCl, 0.5places an Xba restriction site in the place of BIII-CRE. After PCR
mM DTT, and 0.2 mM PMSF). A Dounce homogenizer was used toamplification, the fragment was gel purified, cut with XbaI, gel puri-
generate a lysate containing whole nuclei,which werethen collectedfied, and self ligated. -72BIII-CAT(CRE-) was constructed by ligating
by a brief 2 min centrifugation. The pellets were resuspended ina double-stranded oligonucleotide to a vector made from a BamHI/
0.05±0.1 ml cold extraction buffer (20 mM HEPES-KOH [pH 7.9],XbaI digest of the -108BIII-CAT(CRE-). The double-stranded oligo was
25% glycerol, 400 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mMannealed from the following two single-stranded oligos: 59-GAT
DTT, and 0.2 mM PMSF plus additional protease inhibitors) andCCCTATTTCGAGGCAGAGGAGGTATCATATGACAGCTCT-39 and
mixed continuously for 2 hr at 48C to extract nuclear proteins. Cellu-59-CTAGAGAGCTGTCATATGATACCTCCTCTGCCTCGAAATAGG-39.
lar debris was removed by centrifugation for 2 min at 48C and the-72BIII-CAT D(57±64) and -72BIII-CAT D(65±72) were constructed by
supernatant was stored frozen at 2808C.ligating two separate double-stranded oligonucleotides to a vector
DNA probes were generated by annealing complimentary syn-made from a BamHI/NdeI digest of the -108BIII-CAT. The double-
thetic oligonucleotides and were end labeled using [g-32P]dATP andstranded oligos were annealed from the following single-stranded
T4 polynucleotide kinase. Binding reactions were performed in aoligos: 59GATCCCTATTTCGCAGATCTTGAGGTATCA-39 and 59TAT
total volume of 30 ml containing 5 mM HEPES, 6.5% glycerol, 0.5 mM
GATACCTCAAGATCTGCGAAATAGG-39 for -72BIII-CAT D(57±64)
EDTA, 1 mM DTT, 1 mM MgCl2, 100 mM NaCl, 0.5 mM spermidine, 50and 59-GATCCCAGATCTTAGGCAGAGGAGGTATCA-39 and 59-TAT
mg/ml tRNA, and 10 mg/ml poly dI-dC as nonspecific DNA. Radiola-
GATACCTCCTCTGCCTAAGATCTGG-39 for -72BIII-CAT D(65±72).
belled probe (0.5 pmol, 105 cpm) was incubated with 15 mg nuclear
-47BIII-CAT was constructed from -108BIII-CAT by digestion with extract at room temperature for 60 min. Specificity of the protein±
NdeI (located at -47) and BamHI (located in the 59 polylinker se- DNA complexes was determined by preincubating the extracts with
quence), blunt ended, gel purified, and religated. -30BIII-CAT was
an excess of homologous unlabelled DNA (10 pmol) for 30 min.
constructed by digestion of -108BIII-CAT(CRE-) with XbaI (located
Similarly, competition assays were performed by preincubating with
at -34) and BamHI, blunt ended, gel purified, and religated. -85BIII- an excess of unlabeled competitor DNA. Super-shift antibodies
CAT and -72BIII-CAT were created by PCR subcloning with the (CREB-1, ATF-1, ATF-2, Santa Cruz Biotechnology; aCREB, P-CREB,
primers 59-CAGGGATCCCGTGCACTAGAGTGTCTATTTCG-39 (for Dr. David Ginty) were added to the reactions following the initial
-85BIII-CAT) and 59-CAGGGATCCCTATTTCGAGGCAGAGGAGG-39 incubation and allowed another 60 min at room temperature to bind.
(for -72BIII-CAT) at one end and the primer 59-CAGCTCGAGGTC A polypeptide containing the DNA-binding domain of CREB (1 mg
GACGGTATCG-39. After gel purification, PCR product was digested CREB-1 bZIP, Santa Cruz) and an oligonucleotide containing the
with BamHI/XhoI, gel purified again, and ligated with prepared vec- CRE consensus binding site (Promega) were used as controls for
tor. Vector was prepared by digesting -108BIII-CAT with BamHI these binding studies. Samples were loaded directly onto a 4%
(located in the 59 polylinker sequence) and XhoI (located at 1300). nondenaturing gel (80:1 poly-acrylamide:bis-acrylamide) prerun in
13 TG buffer (50 mM Tris, 380 mM glycine, and 2 mM EDTA [pH
Transfections 8.5]). Electrophoresis was performed at 35 mA for 3±4 hr to resolve
Cells were transfected by a modified calcium phosphate transfec- protein±DNA complexes from free DNA, and then gels were fixed
tion procedure, as described previously (Threadgill et al., 1997). in 20% methanol±20% acetic acid, dried onto Whatman 3MM paper,
Briefly, the culture media was removed and replaced with DMEM and visualized by autoradiography.
at least 1 hr prior to transfection. The calcium phosphate/DNA pre-
cipitate was formed in HEPES buffered saline (pH 7.07) and added Immunofluorescence
dropwise to the DMEM. A total of 9±10 mg of DNA was used per Cultures were fixed with 4% paraformaldehyde in PBS (378C) for 15
min, washed with PBS (2 3 5 min, room temperature), blocked forplate. Typically, this would include of 4±5 mg of reporter construct
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2 hr with 3% bovine serum albumin (BSA) and 0.3% Triton X-100 factor display perinatal loss of sensory and sympathetic neurons
yet develop basal forebrain cholinergic neurons. Cell 76, 1001±1012.in PBS (room temperature), and incubated in the primary antibody
(diluted in the blocking solution) overnight at 48C. After primary Ernfors, P., Lee, K.F., Kucera, J., and Jaenisch, R. (1994a). Lack of
antibody incubation, cells were washed in PBS (3 3 5 min), incu- neurotrophin-3 leads to deficiencies in the peripheral nervous sys-
bated in fluorescene-conjugated goat anti-mouse secondary anti- tem and loss of limb proprioceptive afferents. Cell 77, 503±512.
body for 1 hr, washed in PBS (3 3 5 min), and coverslipped. The Ernfors, P., Lee, K.F., and Jaenisch R. (1994b). Mice lacking brain-
following antibodies were used: mouse anti-CaM kinase IIa (Boeh- derived neurotrophic factor develop with sensory deficits. Nature
ringer Mannheim; 1:200) and mouse anti-CaM kinase IV (Transduc- 368, 147±150.
tion Laboratories; 1:200).
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